Posted by Michael Wonder on 07 Feb 2022
Not so NICE: cancer patients miss out on innovative new treatments
7 February 2022 - Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes
NICE has passed up the opportunity to ensure its evaluation methods support approval of the most innovative and potentially game-changing medicines.
